AgeX Therapeutics, Inc. (AGE)

EBITDA Margin

-13211.54%

TTM · Period ending:

AGE logo

AGE EBITDA Margin

Latest reported-13211.54%
AGE TTM EBITDA Margin (-777.94% → -13211.54%)
High-resolution chart · PNG

AGE ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

AgeX Therapeutics, Inc. EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
-13,211.5385%
-13,212.3077%
3,911.2069%
5,497.006%
13,337.5%
2,375.2688%
-10,293.2515%
-12,137.9747%
-14,798.2759%
-8,104.9587%
-11,063.0137%
-20,100%
-18,215.3846%
-20,750%
-13,464.1509%
-10,726.4706%
-8,322.5806%
-6,794.4444%
-1,605.0728%
-1,035.8094%
-778.6766%
-515.3936%
-524.0063%
-579.8835%
-630.4582%
-686.6319%
-857.9759%
-792.4709%
-673.3981%
-777.937%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.